Dendrite Increases Leadership Position in Japan for Sales Force Effectiveness

  
    
  
  
    
      Dendrite International, Inc. (NASDAQ: DRTE) announced today three 
      contract signings in Japan to expand its leadership position for sales 
      force effectiveness solutions in the world’s 
      second largest pharmaceutical market.
    
    
      One international and two Japanese domestic pharmaceutical companies are 
      adopting Dendrite’s j-forceNET™, 
      a Web-based sales force effectiveness solution for sales 
      representatives, field managers, and home office staff in Japan. Two of 
      the companies also will implement Dendrite’s 
      new j-forceWIRELESS™ system, a mobile-phone 
      solution fully integrated with j-forceNET to further increase the 
      mobility of its sales representatives.
    
    
      Today’s announcement involves 860 sales 
      representatives, which boosts the total number in Japan using Dendrite 
      solutions to more than 25,000, a market share exceeding 40%.
    
    
      j-forceNET integrates all necessary sales and support functions in a 
      single system. Designed specifically for the Asian pharmaceutical 
      market, the solution enables companies to manage all aspects of customer 
      relationships, which includes viewing sales data, entering customer 
      activity information, updating client profiles, accessing corporate 
      resources, and effectively communicating with the home office. The 
      addition of j-forceWIRELESS allows sales representatives to use mobile 
      phones to review and input urgent information, which ensures a quicker 
      response to their customers.
    
    
      “Our success with the j-forceNET solution 
      continues throughout Asia, and the new j-forceWIRELESS platform allows 
      the mobile sales force to access critical customer data anytime and 
      anywhere,” said Jean-Paul Modde, President, 
      Dendrite Asia Pacific. “With the advances in 
      mobile and wireless technology across the Asian region, we are seeing an 
      increased level of interest from pharmaceutical companies to deploy 
      solutions on these highly cost- effective devices.”
    
    
      About Dendrite
    
    
      Founded in 1986, Dendrite International (NASDAQ: DRTE) enables sales, 
      marketing, clinical and compliance solutions for the global 
      pharmaceutical industry. The company has clients in more than 50 
      countries and includes the world's top 20 pharmaceutical companies. For 
      more information, please visit www.dendrite.com.
    
    
      Note: Dendrite is a registered trademark of Dendrite International, Inc.
    
    
      This document may contain forward-looking statements that may be 
      identified by such forward-looking terminology as "expect," "believe," 
      "anticipate," "will," "intend," "plan," "target," "outlook," "guidance," 
      and similar statements or variations. Such forward-looking statements 
      are based on our current expectations, estimates, assumptions and 
      projections and involve significant risks and uncertainties, including 
      risks which may result from our dependence on the pharmaceutical 
      industry; fluctuations in quarterly revenues due to lengthy sales and 
      implementation cycles for certain of our solutions; our fixed expenses 
      in relation to fluctuating revenues and variations in customers' budget 
      cycles; dependence on certain major customers; changes in demand for our 
      products and services attributable to any weakness experienced in the 
      economy or mergers, acquisitions and consolidations in the 
      pharmaceutical industry; successful and timely development and 
      introduction of new products and versions; rapid technological changes; 
      increased competition; international operations; integrating the 
      entities we acquire; our ability to effectively manage our growth; the 
      protection of our proprietary technology; our ability to compete in the 
      Internet-related products and services market; the continued demand for 
      Internet-related products and services; the ability of our third party 
      vendors to respond to technological change; our ability to maintain our 
      relationships with third-party vendors; less favorable than anticipated 
      results from strategic relationships; dependence of data solutions on 
      strategic relationships; events which may affect the U.S. and world 
      economies; and catastrophic events which could negatively affect our 
      information technology infrastructure. Other important factors that 
      should be reviewed and carefully considered are included in the 
      company's 10-K, 10-Qs, and other reports filed with the SEC. Actual 
      results may differ materially. The company assumes no obligation for 
      updating any such forward-looking statements to reflect actual results, 
      changes in assumptions or other changes affecting such forward-looking 
      statements.